Cove Private Wealth’s Edwards Lifesciences EW Stock Holding History

Cove Private Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.18M	Buy	13,712 +10	+0.1%	+$889	0.21%	78
2026 Q2	$1.24M	Hold	13,702	–	–	0.24%	75
2026 Q1	$1.1M	Buy	13,702 +919	+7%	+$75.8K	0.25%	74
2025 Q4	$1.09M	Hold	12,783	–	–	0.32%	69
2025 Q3	$994K	Hold	12,783	–	–	0.31%	74
2025 Q2	$1000K	Buy	12,783 +14	+0.1%	+$1.04K	0.35%	70
2025 Q1	$925K	Hold	12,769	–	–	0.49%	57
2024 Q4	$945K	Hold	12,769	–	–	0.57%	44
2024 Q3	$843K	Hold	12,769	–	–	0.65%	45
2024 Q2	$1.18M	Hold	12,769	–	–	0.94%	31
2024 Q1	$1.22M	Hold	12,769	–	–	1.04%	30
2023 Q4	$974K	Buy	+12,769	New	+$888K	0.92%	36

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Cove Private Wealth's EW Position: Q3 2026 in Review

Cove Private Wealth increased its Edwards Lifesciences (EW) stake by 0.07% in Q3 2026, buying an estimated $889 and bringing the position to 13,712 shares worth $1.18M. The position accounts for 0.21% of the portfolio, ranked #78.

Cove Private Wealth first reported a position in EW in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.24M in Q2 2026. 492 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Cove Private Wealth held 13,712 shares of Edwards Lifesciences worth $1.18M as of Q3 2026.
Cove Private Wealth bought 10 Edwards Lifesciences shares in Q3 2026, an estimated $889.
Edwards Lifesciences made up 0.21% of Cove Private Wealth's portfolio in Q3 2026, its #78 holding.
Cove Private Wealth first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 12 quarters since.
Cove Private Wealth's Edwards Lifesciences position peaked at $1.24M in Q2 2026.
492 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Cove Private Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.